Fraser, Heather <br/><br/>
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jan 2009 
 - 60-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0b013e318195bfbc  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates<br/>Aneurysm<br/>Animals<br/>Aorta--pathology<br/>Apolipoproteins E--deficiency<br/>Arteriosclerosis--enzymology<br/>Atherosclerosis--enzymology<br/>Blood Proteins<br/>Cholesterol<br/>Group II Phospholipases A2<br/>Humans<br/>Indoles<br/>Keto Acids<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Transgenic<br/>Phospholipases A2, Secretory--antagonists & inhibitors